PharmaCyte Biotech Inc (PMCB)
2.19
+0.06
(+2.82%)
USD |
NASDAQ |
May 02, 16:00
2.19
0.00 (0.00%)
After-Hours: 18:44
PharmaCyte Biotech Market Cap: 18.54M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 18.03M |
| April 30, 2024 | 17.95M |
| April 29, 2024 | 17.95M |
| April 26, 2024 | 17.86M |
| April 25, 2024 | 17.95M |
| April 24, 2024 | 18.62M |
| April 23, 2024 | 18.03M |
| April 22, 2024 | 18.79M |
| April 19, 2024 | 17.95M |
| April 18, 2024 | 18.62M |
| April 17, 2024 | 17.95M |
| April 16, 2024 | 18.20M |
| April 15, 2024 | 17.86M |
| April 12, 2024 | 18.88M |
| April 11, 2024 | 19.47M |
| April 10, 2024 | 19.13M |
| April 09, 2024 | 19.47M |
| April 08, 2024 | 20.23M |
| April 05, 2024 | 20.48M |
| April 04, 2024 | 21.33M |
| April 03, 2024 | 21.25M |
| April 02, 2024 | 20.99M |
| April 01, 2024 | 20.70M |
| March 28, 2024 | 20.06M |
| March 27, 2024 | 20.65M |
| Date | Value |
|---|---|
| March 26, 2024 | 20.65M |
| March 25, 2024 | 20.99M |
| March 22, 2024 | 20.65M |
| March 21, 2024 | 20.40M |
| March 20, 2024 | 20.15M |
| March 19, 2024 | 18.11M |
| March 18, 2024 | 17.01M |
| March 15, 2024 | 16.51M |
| March 14, 2024 | 17.38M |
| March 13, 2024 | 16.87M |
| March 12, 2024 | 16.79M |
| March 11, 2024 | 17.13M |
| March 08, 2024 | 17.55M |
| March 07, 2024 | 17.47M |
| March 06, 2024 | 17.30M |
| March 05, 2024 | 17.30M |
| March 04, 2024 | 17.47M |
| March 01, 2024 | 17.72M |
| February 29, 2024 | 17.89M |
| February 28, 2024 | 17.89M |
| February 27, 2024 | 17.21M |
| February 26, 2024 | 17.72M |
| February 23, 2024 | 17.55M |
| February 22, 2024 | 17.55M |
| February 21, 2024 | 17.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.610M
Minimum
Aug 11 2021
80.04M
Maximum
Jan 31 2020
40.91M
Average
45.06M
Median
Mar 23 2020
Market Cap Benchmarks
| CEL-SCI Corp | 79.89M |
| AIM ImmunoTech Inc | 20.13M |
| IGC Pharma Inc | 32.50M |
| NovaBay Pharmaceuticals Inc | 2.682M |
| Protalix BioTherapeutics Inc | 85.11M |
Market Cap Related Metrics
| PS Ratio | 656.15 |
| Price to Book Value | 0.5909 |
| Price | 2.19 |
| Earnings Yield | -54.79% |